Evolocumab use in Greece is associated with early and sustainable reductions in low-density cholesterol (LDL-C) and high persistence to therapy: Results from the Greek cohort analysis of the observational HEYMANS study.

Hellenic J Cardiol

Imperial Centre for Cardiovascular Disease Prevention and Imperial Clinical Trials Unit, Imperial College London, London, UK.

Published: November 2023

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.hjc.2023.09.003	DOI Listing

Publication Analysis

evolocumab greece

greece associated

associated early

early sustainable

sustainable reductions

reductions low-density

low-density cholesterol

cholesterol ldl-c

ldl-c high

high persistence

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!